Report Categories
View AllRecent Articles
View All
Salesforce Inc CRM Bearish Risks Mount Amid AI Pricing Pushback Competitive Pressures and Federal Contract Uncertainty
CapsoVision CV Stock Outlook Q4 2025 EPS Tops Views
2025 US Individual Income Tax Filing Season Refund Trends and Policy Implications
ConocoPhillips COP Supply Shortage Warnings Align With Oil Price Surge Amid Extended Iran Strait of Hormuz Blockade
Chinas Robot Workforce Ambitions Elon Musk Identifies Key Rival in Humanoid Race
Middle East Conflict Challenges Gulf Regions AI Hub Ambitions
Chinese Drone Shipments NoseDive Amid Domestic Restrictions and US Ban
Salesforce Reports Earnings and Revenue Beat But FullYear Outlook Disappoints
Softcat Raises Annual Profit Outlook as AI Infrastructure Demand Surges Amid Chip Shortage
Professional Title AIDriven Hiring Doom Loop JobSeekers and Recruiters in an Arms Race of Homogenized Applications
UTI Q1 2026 Earnings EPS Misses Estimates Amid Positive Stock Movement
Instil Bio Inc TIL Q1 2026 Earnings WiderThanExpected Loss as Biotech Continues PreCommercial Phase
LIXT Q4 2024 Earnings ClinicalStage Biotech Reports perShare Loss as Development Continues
CDIO Q1 2025 Earnings EPS Surprise of 47 Highlights Improved Cost Management
JBHT Q1 2026 Earnings EPS Beats Estimates as Operational Efficiency Drives Performance
UBFO Q4 2025 Earnings Modest Earnings in a Quiet Quarter
Perpetua Resources PPTA Slips 15 as Stock Consolidates Between Key Support and Resistance Levels
Fate Therapeutics Surges Over 10 as Biotech Sector Shows Signs of Life FATE
Lululemon LULU Holds Steady Near Support as Market Eyes Key Resistance Levels
Upbound Group Inc UPBD Edges Higher Amid Modest Gains
Gyre Therapeutics GYRE Falters Testing Key Support After 194 Decline